Antibacterial agent 294
Antibacterial agent 294 is an antibacterial agent. Antibacterial agent 294 shows antibacterial effect against carbapenem-resistant Acinetobacter baumannii (CRAB) with a MIC of 0.5 μg/mL. Antibacterial agent 294 can be used for the research of infection.
For research use only. We do not sell to patients.
- Formula: C16H11N5O6
- Molecular Weight:369.29
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
In Vitro
Antibacterial agent 294 (Compound 7l) (48 h) shows no significant cytotoxicity in Vero cells and NIH-3T3 cells with CC50 values >200 μg/mL[1].
Antibacterial agent 294 (1-2 μg/mL) exhibits potent inhibitory activity against multiple clinical isolates of multidrug-resistant Acinetobacter baumannii (MDR-AB), with an MIC range of 1-2 μg/mL and has a MIC value of 1 μg/mL for the standard strain ATCC-17978[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 369.29
-
Formula C16H11N5O6
-
SMILES
O=C(NNC1=CC=C([N+]([O-])=O)C=C1)C2=NOC(C3=CC([N+]([O-])=O)=CC=C3)=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Antibacterial agent 294 Related Classifications
HY-178384 Related Classifications
Powered by Bioz